📈 Hemas Sustains 1Q Revenue Despite Earnings Dip

• Overall Financial Performance • Revenue: Rs. 28.77 Bn (up 0.9% YoY) • Gross Profit Margin: 30.4% (up 0.2% YoY) • EBITDA: Rs. 2.26 Bn (down 14.1% YoY) • Equity Holders Net Profit: Rs. 937 Mn (down 21.4% YoY) • Operating Costs: Net operating expenses rose 9.0% YoY, driven by a 12.3% YoY surge in selling and distribution costs due to rising fuel, freight, and logistics expenses. • Sector Breakdown & Drivers • Consumer Brands, Hospitals, and Mobility drove revenue growth, while Life Sciences contracted 3.8% YoY. • Finance costs grew due to Rupee depreciation impacting USD borrowings at the Leisure JV, though interest income on net cash holdings provided partial relief. • Strategic Focus & Outlook • Prioritizing cost recovery, margin restoration, calibrated pricing, and productivity enhancements in Consumer Brands and Life Sciences. • Segment reporting updated to break down into Consumer Brands, Life Sciences, Hospitals, Mobility, and Strategic Investments for enhanced management transparency.